[1] AMY J. ESHLEMAN . Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors[J]. Biochemical pharmacology, 2020, 182: Article 114293. DOI:
10.1016/j.bcp.2020.114293[2] LAKSHMI VASUDEVAN . Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform[J]. Biochemical pharmacology, 2020, 177: Article 113910. DOI:
10.1016/j.bcp.2020.113910[3] NEIL B. VARSHNEYA . Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances[J]. Neuropharmacology, 2019, 151: Pages 171-179. DOI:
10.1016/j.neuropharm.2019.03.023[4] D. MATTHEW WALENTINY Patrick M B Léa T Moisa. Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice[J]. Neuropharmacology, 2019, 150: Pages 210-216. DOI:
10.1016/j.neuropharm.2019.02.007